Home

nyak Turbina márka teva fda 2016 Elidegenítés Emigrál Converge

Teva's long-acting schizophrenia drug rejected by FDA | pharmaphorum
Teva's long-acting schizophrenia drug rejected by FDA | pharmaphorum

Teva Wins FDA Approval for First Viagra Generic, Will Not Launch Until 2017  | RAPS
Teva Wins FDA Approval for First Viagra Generic, Will Not Launch Until 2017 | RAPS

Teva shares rally as FDA approves troubled drugmaker's migraine treatment |  The Times of Israel
Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel

FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More
FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More

Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva confirms US FDA warning letter for Hangzhou, China API plant

4"..
4"..

Reslizumab | New Drug Approvals
Reslizumab | New Drug Approvals

FDA approves first generic version of EpiPen - The Washington Post
FDA approves first generic version of EpiPen - The Washington Post

Teva wins FDA approval for first-ever generic Viagra - Globes
Teva wins FDA approval for first-ever generic Viagra - Globes

Epinephrine Auto-injectors: Where is the Long Promised Generic? |  SnackSafely.com
Epinephrine Auto-injectors: Where is the Long Promised Generic? | SnackSafely.com

FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce  Pharma
FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce Pharma

Troubled Teva plant in Hungary faces an FDA crackdown - STAT
Troubled Teva plant in Hungary faces an FDA crackdown - STAT

Teva's Huntington drug launch on hold after FDA rejection | Fierce Biotech
Teva's Huntington drug launch on hold after FDA rejection | Fierce Biotech

Untitled
Untitled

Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA)  | Seeking Alpha
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha

FDA approves Teva's generic EpiPen after yearslong delay
FDA approves Teva's generic EpiPen after yearslong delay

Teva Announces FDA Acceptance of Resubmitted New Drug Application for  SD-809 for Treatment of Chorea Associated with Huntington Disease -  Huntington's Disease News
Teva Announces FDA Acceptance of Resubmitted New Drug Application for SD-809 for Treatment of Chorea Associated with Huntington Disease - Huntington's Disease News

Teva recalls U.S.-made drugs following contamination fears | Pittsburgh  Post-Gazette
Teva recalls U.S.-made drugs following contamination fears | Pittsburgh Post-Gazette

FDA accepts Teva new drug resubmission - Globes
FDA accepts Teva new drug resubmission - Globes

Teva's troubled Godollo plant earns firm US FDA warning letter
Teva's troubled Godollo plant earns firm US FDA warning letter

Teva Shares Rise Following FDA Approval of Migraine Drug | Ctech
Teva Shares Rise Following FDA Approval of Migraine Drug | Ctech

FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce  Pharma
FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce Pharma

Teva Pharmaceuticals - pdf download
Teva Pharmaceuticals - pdf download

Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?
Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?

FDA approves first generic version of epilepsy drug Sabril from Teva
FDA approves first generic version of epilepsy drug Sabril from Teva

Teva halts production at sterile injectables plant to address FDA concerns  | Fierce Pharma
Teva halts production at sterile injectables plant to address FDA concerns | Fierce Pharma